Spruce Biosciences, Inc.
SPRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001683553
No open-market purchases or sales by Spruce Biosciences, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $116.3M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Spruce Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 41 | 44 | +3 |
| Shares | 20.1M | 19.6M | −456.3K (−2.3%) |
| Value | $225.3M | $118.1M | −$107.2M (−47.6%) |
New holders (7)
Institutions that held Spruce Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sands Capital Ventures, LLC | 787,007 | $4.73M | 0.71% |
| Renaissance Technologies LLC | 34,000 | $204.0K | 0.00% |
| Jacobs Levy Equity Management, Inc | 24,361 | $146.0K | 0.00% |
| Two Sigma Advisers, LP | 19,200 | $115.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 17,440 | $105.0K | 0.00% |
| Trexquant Investment LP | 11,998 | $72.0K | 0.01% |
| Ellevest, Inc. | 31 | $0 | 0.00% |
Sold out (4)
Institutions that held Spruce Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Sands Capital Management, LLC | 787,007 | $8.82M |
| Adage Capital Partners GP, L.L.C. | 240,511 | $2.70M |
| Alyeska Investment Group, L.P. | 19,413 | $218.0K |
| STRS Ohio | 2,400 | $26.0K |